Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.16)
# 3,626
Out of 4,945 analysts
485
Total ratings
30.32%
Success rate
-15.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $22 → $19 | $9.75 | +94.87% | 25 | Aug 14, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $42 | $17.81 | +135.82% | 11 | Aug 12, 2025 | |
| EXEL Exelixis | Maintains: Buy | $53 → $46 | $38.26 | +20.23% | 10 | Aug 12, 2025 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $12 → $10 | $2.76 | +262.32% | 14 | Aug 11, 2025 | |
| YMAB Y-mAbs Therapeutics | Downgrades: Neutral | $11 → $8.6 | $8.52 | +1.00% | 22 | Aug 6, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $22 → $21 | $11.50 | +82.61% | 13 | Aug 6, 2025 | |
| CRDF Cardiff Oncology | Maintains: Buy | $18 → $10 | $2.40 | +317.54% | 3 | Aug 6, 2025 | |
| ACET Adicet Bio | Assumes: Buy | $4 | $0.67 | +497.82% | 1 | Jul 23, 2025 | |
| REPL Replimune Group | Downgrades: Neutral | n/a | $5.29 | - | 18 | Jul 23, 2025 | |
| ELTX Elicio Therapeutics | Maintains: Buy | $10 → $13 | $9.90 | +31.31% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.48 | - | 2 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $10.45 | +225.36% | 16 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $13 | $14.11 | -7.87% | 21 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $11.02 | +108.63% | 1 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $19.78 | +142.67% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $138 | $111.92 | +23.30% | 43 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.16 | +224.07% | 8 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $41 | $11.41 | +259.49% | 4 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.81 | +327.05% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $72 | $35.58 | +102.36% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.93 | +440.54% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.86 | +61.29% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $6.76 | +92.31% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.02 | +164.90% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.93 | +154.45% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.55 | +29.03% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.58 | +217.46% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.03 | +680.49% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.65 | +1,183.02% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.65 | +277.36% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.59 | +214.47% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.32 | +381.93% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.46 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $11.81 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.27 | +766.14% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.86 | +3,312.97% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $5.63 | +4,162.88% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.67 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.60 | +9,275.00% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.07 | +557.28% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $1.78 | +519.72% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $4.21 | +1,068,783.61% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.51 | +612.25% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.95 | +568.38% | 1 | Jan 7, 2021 |
ORIC Pharmaceuticals
Aug 14, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $9.75
Upside: +94.87%
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $17.81
Upside: +135.82%
Exelixis
Aug 12, 2025
Maintains: Buy
Price Target: $53 → $46
Current: $38.26
Upside: +20.23%
Black Diamond Therapeutics
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.76
Upside: +262.32%
Y-mAbs Therapeutics
Aug 6, 2025
Downgrades: Neutral
Price Target: $11 → $8.6
Current: $8.52
Upside: +1.00%
Cogent Biosciences
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $21
Current: $11.50
Upside: +82.61%
Cardiff Oncology
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.40
Upside: +317.54%
Adicet Bio
Jul 23, 2025
Assumes: Buy
Price Target: $4
Current: $0.67
Upside: +497.82%
Replimune Group
Jul 23, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.29
Upside: -
Elicio Therapeutics
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.90
Upside: +31.31%
Jul 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.48
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $10.45
Upside: +225.36%
Jul 3, 2025
Reiterates: Neutral
Price Target: $13
Current: $14.11
Upside: -7.87%
Jul 3, 2025
Initiates: Buy
Price Target: $23
Current: $11.02
Upside: +108.63%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $19.78
Upside: +142.67%
Jun 25, 2025
Reiterates: Buy
Price Target: $138
Current: $111.92
Upside: +23.30%
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.16
Upside: +224.07%
May 16, 2025
Maintains: Buy
Price Target: $44 → $41
Current: $11.41
Upside: +259.49%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.81
Upside: +327.05%
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $35.58
Upside: +102.36%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.93
Upside: +440.54%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.86
Upside: +61.29%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $6.76
Upside: +92.31%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $3.02
Upside: +164.90%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $3.93
Upside: +154.45%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.55
Upside: +29.03%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.58
Upside: +217.46%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.03
Upside: +680.49%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.65
Upside: +1,183.02%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.65
Upside: +277.36%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.59
Upside: +214.47%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.32
Upside: +381.93%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.46
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $11.81
Upside: -
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.27
Upside: +766.14%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.86
Upside: +3,312.97%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $5.63
Upside: +4,162.88%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.67
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $1.60
Upside: +9,275.00%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.07
Upside: +557.28%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $1.78
Upside: +519.72%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $4.21
Upside: +1,068,783.61%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.51
Upside: +612.25%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.95
Upside: +568.38%